X-Therma's Latest News
Read the latest news about X-Therma, Cryopreservation and Biopreservation.
X-Therma Achieves GMP Commercial Readiness with XT-Thrive®
X-Therma Inc., a biotechnology company developing a breakthrough platform for regenerative medicine and organ preservation, has achieved GMP (Good Manufacturing Practice) commercial readiness with its
X-Therma Announces XT-Thrive® Drug Master File (DMF) Accepted by U.S. Food and Drug Administration (FDA)
X-Therma Inc., a biotechnology company developing a breakthrough platform for regenerative medicine and organ preservation, announces that the Food and Drug Administration (FDA) accepted a
X-Therma’s $22.4M Series B Sets Stage to Transform Regenerative Medicine and Organ Transplantation
Image: Xiaoxi Wei, Ph.D., Co-founder and CEO of X-Therma, with the TimeSeal® Oversubscribed round propels company towards clinical trials and global market expansion, promising
Preserve Mammalian Cells At Ultra-Low Temperatures With XT-Thrive®
XT-Thrive® is a DMSO-free, serum-free, protein-free, and chemically defined cryopreservation media for the preservation of mammalian cells at ultra-low temperatures (-70° C to -196° C).
XT-ViVo® & TimeSeal® Multi-Day Preservation of Organs, Tissues And Cells
Learn how XT-ViVo® & TimeSeal® will enable multi-day preservation and remove time from the equation. The global shortage of transplantable organs is considered one of
Advancing Treatment For Type 1 Diabetes With Drs. Camillo Ricordi And Xiaoxi Wei
Dr. Camillo Ricordi may be a familiar name to anyone who has, or has known someone, with type 1 diabetes. As director of the Diabetes
The Future Of DMSO-Free And Serum-Free Cryopreservation For Advanced Therapies
Cryopreservation is a crucial part of bioprocessing and biopharmaceutical manufacturing, storage, and transport – by using very low temperatures top reserve cells, cryopreservation can enable
Science Chops Alone Don’t Cut It: The Entrepreneurial Growth Struggle
In the eight years since launching X-Therma, we’ve achieved chemistry breakthroughs that we believe will truly propel the field of organ transplant to a new
Next-Generation Cryopreservation Techniques: Improving Cold Chain Management For Regenerative Medicines
Cryopreservation has become a crucial component in realizing the large-scale commercial manufacturing of regenerative medicines, which require unique storage and transport strategies to ensure their
